Frontlight ResearchEarly access
TerminatedNo phase
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer
Key facts
- Who runs it
- M.D. Anderson Cancer Center
- Where
- Houston, United StatesSee the 2 sites
- Trial code
- Status
- Terminated
- People taking part
- 409 people enrolled
- Started
- 27 Oct 2014
- Ended
- 8 Jul 2025
- Type of study
- Interventional
- Treatments tested
- Biospecimen Collection
- Laboratory Biomarker Analysis
- Record updated
- 14 July 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Women with histologically confirmed cervical, vaginal or vulvar high-grade dysplasia, invasive squamous cell carcinoma, invasive adenocarcinoma, or adenocarcinoma-in-situ (AIS). All stages and grades will be eligible
- Women with a diagnosis of high grade intraepithelial lesion (HSIL) from a routine pap test
- Patients must sign an approved informed consent document
Who cannot take part
- Patients with previously documented perianal squamous cell dysplasia or invasive squamous cell carcinoma of the anus or anal canal
- Patients with previously documented HPV related oropharyngeal cancer
- Patients unwilling or unable to provide informed consent for the study
- Male patients will not be included in this study
Where in United States
- Lyndon Baines Johnson General HospitalHouston, United States
- M D Anderson Cancer CenterHouston, United States
About the trial
What the trial wants to find out
This trial studies the prevalence of anal dysplasia and anal cancer in patients with cervical, vaginal, and vulvar dysplasia and cancer. Studying samples collected from patients in the laboratory may help doctors learn more about the human papillomavirus and how often anal cancer occurs in patients with cervix, vagina, or vulvar cancer.
The group in the trial
- Screening (biospecimen collection)Treatment being tested
Patients undergo collection of anal, cervical, vaginal, and oral samples during their scheduled pelvic exam.
Treatment: Biospecimen Collection and Laboratory Biomarker Analysis
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prevalence of Anal Dysplasia and Anal Cancer in Women With Cervical, Vaginal and Vulvar Dysplasia and Cancer
- Record updated
- 14 July 2025